Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Versus Long-term Venlafaxine XR in GAD
NCT00183274Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2004
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine in generalized anxiety disorder (GAD), sponsored by University of Pennsylvania. Started Jan 2004; status: completed.
02
Drugs
venlafaxine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00183274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183274.